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on-valve technique). With the technique described herein, the
mechanical prosthesis is not removed in its entirety because the
valve housing is left in situ, and the leaflets are simply unhinged.
We have found this not to be an issue with thrombus formation in
this and in 2 additional cases performed at our institution because
the smooth surface of the housing and the high flow within the left
ventricular outflow tract are most likely protective against recur-
rent thrombosis after removal of the leaflets.
The technique reported is reliable, easily reproducible, and
offers reduced crossclamp time, potential for bleeding, and coro-
nary malperfusion to this challenging group of reoperative pa-
tients.
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Bovine jugular vein as a shaped alternative patch material for aortic
augmentation in the Norwood procedure
David G. Healy, MRCSI, Lars Nolke, FRCSI, and Alfred E. Wood, FRCSI, Dublin, Ireland
The Norwood procedure is commonly performed with apatch augmentation of the neoaorta. Homograft pulmo-nary conduits are used, but the opportunity cost of thisscarce resource has prompted the evaluation of alterna-
tives. We have used bovine jugular vein as an alternative aortic
patch augmentation material with early success.
Clinical Summary
The Medtronic Contegra bioprosthesis (Medtronic, Inc, Minneap-
olis, Minn) consists of a bovine jugular vein with a trileaflet
venous valve. It is preserved under minimal pressure (3 mm Hg)
in a 0.25% buffered glutaraldehyde solution and is terminally
sterilized in a formulation of glutaraldehyde and isopropyl alcohol.
It is available in a range of sizes (12–22-mm internal diameter) and
is between 7- and 10-cm long with the valve centered on the
prosthesis. We have used this patch technique in 3 cases of
hypoplastic left heart syndrome, applying the technique described
by Norwood with the Sano modification.1
The Contegra graft is prepared by being rinsed in normal saline
for 15 minutes. No thawing or preclotting is required. While the
patch is cooling, the surgeon prepares it as shown in Figure 1.
The reconstruction was satisfactory and bleeding was within
expected limits in all 3 patients. Delayed sternal closure was
adopted and none required reintervention for bleeding. Echocar-
diographic studies postoperatively demonstrated good anatomic
reconstruction, and they have all survived to hospital discharge and
are awaiting the second stage of palliation.
Discussion
The original Norwood procedure did not use a patch to reconstruct
the aorta. This was instead proposed by Jonas and associates2 in
1986 in a successful attempt to address the commonly associated
hypoplastic arch and aortic coarctation. Contemporary attempts
have even been made to reconstruct the aorta without the use of
any graft material.3 However, the applicability of this technique is
limited by the anatomy of the child. Fifteen percent of patients in
the Ishino series3 required patch material. This group has subse-
quently moved to a patch aortic augmentation technique for this
reason and because of the technical difficulty of a patchless tech-
nique. In addition, the neoaorta reconstructed at this time is ex-
pected to endure for life, and a final shape with physiologic flow
characteristics should continue to be the surgical aim.
Synthetic material for patch aortic augmentation has not been
widely reported, and there are no randomized comparisons be-
tween synthetic material and pulmonary homograft. This may
reflect the perceived established benefits of biological material as
a vascular patch material. Pulmonary homograft for the reconstruc-
tion of the aorta is considered the ideal material because of its good
hemostatic and handling properties and the appropriateness of
using a vessel graft for vascular reconstruction. However, limited
availability of pulmonary homografts has motivated the search for
alternatives. Allograft material is also associated with calcification
and may reduce the transplantation options, as allograft material
used in Norwood procedures is associated with the generation of
cytotoxic antibodies.4
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Other xenografts have been proposed, such as bovine pericar-
dium. This offers many of the advantages of the bovine jugular
vein patch, but without the advantages of having an intrinsic
natural conduit shape. However, there are few reports of the use of
this material since the original description in 1999.5 Bovine jugular
conduits are being widely used for reconstruction of the right ven-
tricular outflow tract. Their recent arrival precludes long-term
follow-up data, but experience to date shows satisfactory perfor-
mance. Where reintervention has been required, the problems have
been related largely to valve degeneration and to stenosis at the
anastomotic site for these tube grafts, something less likely in cases in
which the material has been used as a patch augmentation. There is
limited experience with the graft on the systemic side. Indeed, the
manufacturer does not support the use of this venous valved device as
a left-sided valve conduit. However, used as a patch material rather
then a valve, the bovine jugular vein offers many advantages in the
performance of the Norwood procedure. These include ready avail-
ability, a size spectrum, cost-effectiveness, and avoidance of trans-
mission of human viral pathogens. Its most distinctive feature, how-
ever, is the tube properties of this graft material that render it a useful
alternative to pulmonary homografts for reconstruction of the aorta in
hypoplastic left heart syndrome.
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Figure 1. A, The tube conduit is filleted, exposing the inner surface
and valve leaflets. B, The conduit is divided distal to the leaflets, and
this portion is subsequently used for the patch. C, The patch is sized
by the surgeon and cut from the xenograft . D, The xenograft is used
as shown as a augmentation patch for the neoaorta.
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